REGULATORY INTELLIGENCE·Warning Letter
Neogen Corporation Faces FDA Class II Recall for LICEOUT Amidst CGMP Violations: Supply Chain and Regulatory Implications
Neogen Corporation has initiated a Class II recall of 5,328 sachets of LICEOUT, a liquid lice treatment, due to critical CGMP violations at its Lexington, KY facility. This event necessitates immediate action for procurement directors and supply chain VPs to assess continuity, especially for institutional distributors like Bob Barker Company, and highlights the imperative for robust supplier quality assurance.
90-Day Activity